Literature DB >> 16505032

Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma.

Michael R Steele1, Denise M Inman, David J Calkins, Philip J Horner, Monica L Vetter.   

Abstract

PURPOSE: The DBA/2J mouse is a model for secondary angle-closure glaucoma, due to iris atrophy and pigment dispersion, which ultimately lead to increased intraocular pressure (IOP). The study was undertaken to correlate changes in retinal gene expression with IOP elevation by performing microarray analysis of retinal RNA from DBA/2J mice at 3 months before disease onset and at 8 months after IOP elevation.
METHODS: IOP was monitored monthly in DBA/2J animals, and animals with normal (3 months) or elevated IOP (8 months) were identified. RNA was prepared from three individual retinas at each age, and the RNA was amplified and used to generate biotin-labeled probe for high-density mouse gene microarrays (U430.2; Affymetrix, Santa Clara, CA). A subset of genes was selected for confirmation by quantitative RT-PCR, by using independent retina samples from DBA/2J animals at 3, 5, and 8 months of age and compared to retinas from C57BL/6J control animals at 3 and 8 months.
RESULTS: There were changes in expression of 68 genes, with 32 genes increasing and 36 genes decreasing at 8 months versus 3 months. Upregulated genes were associated with immune response, glial activation, signaling, and gene expression, whereas downregulated genes included multiple crystallin genes. Significant changes in nine upregulated genes and two downregulated genes were confirmed by quantitative RT-PCR, with some showing changes in expression by 5 months.
CONCLUSIONS: DBA/2J retina shows evidence of glial activation and an immune-related response after IOP elevation, similar to what has been reported after acute elevation of IOP in other models.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505032     DOI: 10.1167/iovs.05-0865

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  112 in total

1.  Localization and phenotype-specific expression of ryanodine calcium release channels in C57BL6 and DBA/2J mouse strains.

Authors:  Wei Huang; Wei Xing; Daniel A Ryskamp; Claudio Punzo; David Križaj
Journal:  Exp Eye Res       Date:  2011-09-14       Impact factor: 3.467

2.  Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action.

Authors:  Grace C Shih; David J Calkins
Journal:  Expert Rev Ophthalmol       Date:  2012-04

Review 3.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

Review 4.  Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms.

Authors:  S D Crish; D J Calkins
Journal:  Neuroscience       Date:  2010-12-25       Impact factor: 3.590

5.  Global gene expression changes in rat retinal ganglion cells in experimental glaucoma.

Authors:  Dan Yi Wang; Arjun Ray; Kathryn Rodgers; Ceren Ergorul; Bradley T Hyman; Wei Huang; Cynthia L Grosskreutz
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-24       Impact factor: 4.799

6.  Anterior segment dysgenesis and early-onset glaucoma in nee mice with mutation of Sh3pxd2b.

Authors:  Mao Mao; Adam Hedberg-Buenz; Demelza Koehn; Simon W M John; Michael G Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-01       Impact factor: 4.799

7.  Missing optomotor head-turning reflex in the DBA/2J mouse.

Authors:  Peter Barabas; Wei Huang; Hui Chen; Christopher L Koehler; Gareth Howell; Simon W M John; Ning Tian; René C Rentería; David Krizaj
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

Review 8.  Focus on molecular events in the anterior chamber leading to glaucoma.

Authors:  Sergio Claudio Saccà; Alberto Izzotti
Journal:  Cell Mol Life Sci       Date:  2013-10-19       Impact factor: 9.261

9.  Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.

Authors:  Alejandra Bosco; Sarah R Anderson; Kevin T Breen; Cesar O Romero; Michael R Steele; Vince A Chiodo; Sanford L Boye; William W Hauswirth; Stephen Tomlinson; Monica L Vetter
Journal:  Mol Ther       Date:  2018-08-24       Impact factor: 11.454

10.  Innate immune network in the retina activated by optic nerve crush.

Authors:  Justin P Templeton; Natalie E Freeman; John M Nickerson; Monica M Jablonski; Tonia S Rex; Robert W Williams; Eldon E Geisert
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.